Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics
In This Article:
Merus stock rocketed — and hammered Bicara — after unveiling promising new results for its experimental head-and-neck cancer treatment.
Oops, something went wrong
Merus stock rocketed — and hammered Bicara — after unveiling promising new results for its experimental head-and-neck cancer treatment.